Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis - Dimopoulos, Meletios A; Moreau, Philippe; Augustson, Bradley; Castro, Nelson; Pika, Tomas; Delimpasi, Sosana; De la Rubia, Javier; Maiolino, Angelo; Reiman, Tony; Martinez-Lopez, Joaquin; Martin, Thomas; Mikhael, Joseph; et al. (American journal of hematology, 2023)
Keywords: humanizované monoklonální protilátky; Antibodies, Monoclonal, Humanized; dexamethason; Neoplasm Recurrence, Local; Dexamethasone; lidé; mnohočetný myelom; Multiple Myeloma; lokální recidiva nádoru; Antineoplastic Combined Chemotherapy Protocols; Humans; protokoly protinádorové kombinované chemoterapie